Question · asked by 1 review
Anti‐TNF disease activity–guided dose tapering vs anti‐TNF continuation: Withdrawals due to adverse events not measured
- Population
- people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
- Intervention
- Anti‐TNF disease activity–guided dose tapering
- Comparison
- anti‐TNF continuation
- Outcome
- Withdrawals due to adverse events not measured
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Anti‐TNF disease activity–guided dose tapering vs anti‐TNF continuation Withdrawals due to adverse events ‐ not measured · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents The review found no eligible studies for this question. Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid… (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low… 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.